Ensure the Pfizer and Flynn Pharma CMA fines are used solely to improve NHS care

Closed 1,336 signatures

What the petition asks

Pharmaceutical companies Pfizer and Flynn Pharma have been fined a total of £89.4m by the Competition and Marketing Authority for exploiting a monopoly position over the marketing of the epilepsy drug Epanutin. Their actions have cost the NHS an estimated £44m per year for the last 4 years.

The cost of this scandal has been entirely born by the NHS, and if all the fines are returned to the NHS it will still fall short of the £176m extra the NHS has had to pay for this vital drug. Patients with epilepsy have been most affected, and so some of the money should be used to employ Epilepsy Nurses to improve epilepsy care. See https://binscombedoctorblog.wordpress.com/2012/10/06/the-marketing-of-epanutin-re-energising-a-product-for-an-underserved-population-or-big-pharma-behaving-badly/

Timeline

15 Dec 2016	Petition opened for signatures
2 May 2017	Closed to new signatures

Key facts

Signatures 1,336

Status Closed

Opened 15 Dec 2016

Closed 2 May 2017

Follow this petition